Samantha McLemore - Patient Capital Management
Holding/activity history for Royalty Pharma plc (RPRX)
← All RPRX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 3,643,716 | 6.52 | Add 9.30% | 0.55 | $38.51–49.06 · VW $43.81i | $174,789,053 | SEC |
| 2025 Q4 | 3,333,675 | 4.97 | Add 6.92% | 0.32 | $35.23–41.24 · VW $38.47i | $128,813,194 | SEC |
| 2025 Q3 | 3,117,850 | 4.40 | Add 4.35% | 0.18 | $34.08–38.00 · VW $36.13i | $109,997,741 | SEC |
| 2025 Q2 | 2,987,988 | 4.86 | Add 0.52% | 0.03 | $29.66–36.43 · VW $33.37i | $107,657,202 | SEC |
| 2025 Q1 | 2,972,646 | 4.76 | Add 3.39% | 0.16 | $25.40–34.20 · VW $31.91i | $92,538,459 | SEC |
| 2024 Q4 | 2,875,089 | 3.38 | Add 40.85% | 0.98 | $24.05–28.38 · VW $26.19i | $73,343,527 | SEC |
| 2024 Q3 | 2,041,195 | 2.84 | Add 43.30% | 0.86 | $25.20–29.37 · VW $27.64i | $57,745,414 | SEC |
| 2024 Q2 | 1,424,390 | 1.99 | Add 0.32% | <0.01 | $26.10–30.55 · VW $27.71i | $37,561,164 | SEC |
| 2024 Q1 | 1,419,818 | 2.10 | Add 13.15% | 0.24 | $27.17–31.66 · VW $29.54i | $43,119,875 | SEC |
| 2023 Q4 | 1,254,780 | 1.87 | Buy | 1.87 | $26.07–29.63 · VW $27.45i | $35,246,779 | SEC |
Price snapshot:
Current price$56.45
Avg. buy price$30.32
+/- since buy86.17%
52-week low$33.57
52-week high$58.84